2027 Advisory Committee

The Advisory Committee is an esteemed group of industry thought leaders assembled by BIO to shape this event’s conference program by collaboratively identifying topics and speakers that will facilitate engaging and informative discussions.

 

Gad Berdugo

Managing Partner, Explorium Capital LLC

Rajeev Dadoo, PhD

COO and Managing Partner of SR One 

Rich Daly

President, Global Rare Disease, Angelini Pharma

Michelle Doig

Partner, Head of Corporate Development, Omega Funds

Chris Garabedian

CEO, Xontogeny 

Mark Glickman

CEO, BioFlorida  

Sara Nayeem, MD

Independent Consultant

Marta New, PhD, MBA

Chief Strategy Officer, LevelSet Bio

Carolyn Ng, PhD

Partner and Managing Director, TPG Life Sciences Innovations 

John Norris

Managing Director, HSBC Innovation

Philip S. Ross, MD

Chairman Global Healthcare, Investment Banking, Jefferies 

Jennifer Sheng

Managing Director, Head of Healthcare Equity Capital Markets

Chidozie Ugwumba

Founder & Managing Partner, SymBiosis

Asish Xavier, PhD

Chief Strategy & Operations Office and Vice President, Venture Investments, Johnson & Johnson Innovation- JJDC